The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene

Molecular Pharmacology

Volumn 74, Issue 6, 2008, Pages 1716-1721

  Wang, Yongjun ^a,d   Rogers, Pamela M ^a   Stayrook, Keith R ^b   Su, Chen ^b   Varga, Gabor ^b   Shen, Qi ^c   Nagpal, Sunil ^c   Burris, Thomas P ^a,d  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c PFIZER INC   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LIPID RAFT; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SELADIN 1 GENE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL LINE; DNA-BINDING PROTEINS; HUMANS; INTRONS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; SKIN;

EID: 57349194627     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.048538     Document Type: Article

References (34)

1. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B, and Dotti CG (2004) Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167:953-960.
2. Brown J 3rd, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, et al. (2004) Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem 279: 34674-34681.
3. Burns MP, Vardanian L, Pajoohesh-Ganji A, Wang L, Cooper M, Harris DC, Duff K, and Rebeck GW (2006) The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo. J Neurochem 98:792-800.
4. Burris TP, Guo W, Le T, and McCabe ER (1995) Identification of a putative steroidogenic factor-I response element in the DAX-1 promoter. Biochem Biophys Res Commun 214:576-581.
5. Cecchi C, Rosati F, Pensalfini A, Formigli L, Nosi D, Liguri G, Dichiara F, Morello M, Danza G, Pieraccini G, et al. (2008) Seladin-1/DHCR24 protects neuroblastoma cells against Aβ toxicity by increasing membrane cholesterol content. J Cell Mol Med, in press.
6. Crameri A, Biondi E, Kuehnle K, Lütjohann D, Thelen KM, Perga S, Dotti CG, Nitsch RM, Ledesma MD, and Mohajeri MH (2006) The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J 25:432-443.
7. Ehehalt R, Keller P, Haass C, Thiele C, and Simons K (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160:113-123.
8. Feingold KR (2007) Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48:2531-2546.
9. Fernandes MA, Proençogueira AJ, Oliveira LM, Santiago B, Santana I, and Oliveira CR (1999) Effects of apolipoprotein E genotype on blood lipid composition and membrane platelet fluidity in Alzheimer's disease. Biochim Biophys Acta 1454:89-96.
10. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, and Nitsch RM (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345-7352.
11. Hu T, Foxworthy P, Siesky A, Ficorilli JV, Gao H, Li S, Christe M, Ryan T, Cao G, Eacho P, et al. (2005) Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha. Endocrinology 146:5380-5387.
12. Iivonen S, Hiltunen M, Alafuzoff I, Mannermaa A, Kerokoski P, Puoliväli J, Salminen A, Helisalmi S, and Soininen H (2002) Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease. Neuroscience 113:301-310.
13. Jick H, Zornberg GL, Jick SS, Seshadri S, and Drachman DA (2000) Statins and the risk of dementia. Lancet 356:1627-1631.
14. Koldamova RP, Lefterov IM, Ikonomovic MD, Skoko J, Lefterov PI, Isanski BA, DeKosky ST, and Lazo JS (2003) 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion. J Biol Chem 278:13244-13256.
15. Koldamova RP, Lefterov IM, Staufenbiel M, Wolfe D, Huang S, Glorioso JC, Walter M, Roth MG, and Lazo JS (2005) The liver X receptor ligand T0901317 decreases amyloid β production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem 280:4079-4088.
16. Kuehnle K, Crameri A, Kälin RE, Luciani P, Benvenuti S, Peri A, Ratti F, Rodolfo M, Kulic L, Heppner FL, et al. (2008) Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Mol Cell Biol 28:539-550.
17. Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D, and Roher AE (1998) Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun 252:711-715.
18. Ledesma MD, Abad-Rodriguez J, Galvan C, Biondi E, Navarro P, Delacourte A, Dingwall C, and Dotti CG (2003) Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep 4:1190-1196.
19. Michael LF, Schkeryantz JM, and Burris TP (2005) The pharmacology of LXR. Mini Rev Med Chem 5:729-740.
20. Puglielli L, Tanzi RE, and Kovacs DM (2003) Alzheimer's disease: the cholesterol connection. Nat Neurosci 6:345-351.
21. Riddell DR, Zhou H, Comery TA, Kouranova E, Lo CF, Warwick HK, Ring RH, Kirksey Y, Aschmies S, Xu J, et al. (2007) The LXR agonist T0901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol Cell Neurosci 34:621-628.
22. Sandelin A and Wasserman WW (2005) Prediction of Nuclear Hormone Receptor Response Elements. Mol Endocrinol 19:595-606.
23. Savkur RS, Thomas JS, Bramlett KS, Gao Y, Michael LF, and Burris TP (2005) Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor γ coactivator-1 α. J Pharmacol Exp Ther 312:170-178.
24. Schmuth M, Jiang YJ, Dubrac S, Elias PM, and Feingold KR (2008) Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res 49:499-509.
25. Simons K and Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31-39.
26. Stayrook KR, Bramlett KS, Savkur RS, Ficorilli J, Cook T, Christe ME, Michael LF, and Burris TP (2005) Regulation of carbohydrate metabolism by the farnesoid X receptor. Endocrinology 146:984-991.
27. Stayrook KR, Rogers PM, Savkur RS, Wang Y, Su C, Varga G, Bu X, Wei T, Nagpal S, Liu XS, et al. (2008) Regulation of human 3α-hydroxysteroid dehydrogenase (AKR1C4) expression by the liver X receptor α. Mol Pharmacol 73:607-612.
28. Sun Y, Yao J, Kim TW, and Tall AR (2003) Expression of liver X receptor target genes decreases cellular amyloid β peptide secretion. J Biol Chem 278:27688-27694.
29. Varga G and Su C (2007) Classification and predictive modeling of liver X receptor response elements. Biodrugs 21:117-124.
30. Waterham HR, Koster J, Romeijn GJ, Hennekam RC, Vreken P, Andersson HC, FitzPatrick DR, Kelley RI, and Wanders RJ (2001) Mutations in the 3beta-ydroxysterol delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69:685-694.
31. Whitney KD, Watson MA, Collins JL, Benson WG, Stone TM, Numerick MJ, Tippin TK, Wilson JG, Winegar DA, and Kliewer SA (2002) Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol Endocrinol 16:1378-1385.
32. Yoshikawa T, Ide T, Shimano H, Yahagi N, Amemiya-Kudo M, Matsuzaka T, Yatoh S, Kitamine T, Okazaki H, Tamura Y, et al. (2003) Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol Endocrinol 17:1240-1254.
33. Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, and Tontonoz P (2007) Attenuation of neuroinflammation and Alzheimer's disease pathology by liver X receptors. Proc Natl Acad Sci U S A 104:10601-10606.
34. Zelcer N and Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Investig 116:607-614.